NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 11,912,678
- Share change
- -2,391,339
- Total reported value
- $10,125,354
- Price per share
- $0.85
- Number of holders
- 27
- Value change
- -$4,196,499
- Number of buys
- 6
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.6%
|
6,909,220
|
$8,567,433 | — | 30 Sep 2024 | |
| Caligan Partners LP |
13F
|
Company |
1.3%
|
3,499,330
|
$4,339,169 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
1,419,080
|
$1,759,659 | — | 30 Sep 2024 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.21%
|
566,650
|
$702,646 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.19%
|
499,300
|
$619,132 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.15%
|
408,519
|
$506,564 | — | 30 Sep 2024 | |
| EDBI Pte Ltd |
13F
|
Company |
0.08%
|
222,136
|
$275,449 | — | 30 Sep 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.06%
|
162,580
|
$201,599 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
98,389
|
$122,002 | — | 30 Sep 2024 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.03%
|
74,723
|
$92,657 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
63,800
|
$79,112 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
58,358
|
$72,364 | — | 30 Sep 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
43,039
|
$53,368 | — | 30 Sep 2024 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
31,535
|
$39,103 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
30,647
|
$38,002 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
30,370
|
$37,659 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
22,037
|
$27,325 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
13,351
|
$16,555 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0%
|
11,325
|
$14,043 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0%
|
10,685
|
$13,249 | — | 30 Sep 2024 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0%
|
10,000
|
$12,400 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
4,015
|
$4,979 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
1,438
|
$1,783 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
1,367
|
$1,693 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,191
|
$1,471 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
568
|
$703 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
50
|
$62 | — | 30 Sep 2024 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2024
As of 31 Dec 2024,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,912,678 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., MORGAN STANLEY, SG Americas Securities, LLC, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, EDBI Pte Ltd, abrdn plc, CANTOR FITZGERALD, L. P., BNP PARIBAS FINANCIAL MARKETS, and UBS Group AG.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
27
Q4 2024 holders
27
Holder diff
0
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.